The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Acute Hepatitis C Virus Infection in Young Adult Injection Drug Users: A Prospective Study of Incident Infection, Resolution, and Reinfection
Open accessAbstract
BACKGROUND: Hepatitis C virus (HCV) infection, clearance, and reinfection are best studied in injection drug users (IDUs), who have the highest incidence of HCV and are likely to represent most infections. METHODS: A prospective cohort of HCV-negative young IDUs was followed up from January 2000 to September 2007, to identify acute and incident HCV and prospectively study infection outcomes. RESULTS: Among 1,191 young IDUs screened, 731 (61.4%) were HCV negative, and 520 (71.1%) of the 731 were enrolled into follow-up. Cumulative HCV incidence was 26.7/100 person-years of observation (95% confidence interval [CI], 21.5-31.6). Of 135 acute/incident HCV infections, 95 (70.4%) were followed; 20 (21.1%) of the 95 infections cleared. Women had a significantly higher incidence of viral clearance than did men (age-adjusted hazard ratio, 2.91 [95% CI, 1.68-5.03]) and also showed a faster rate of early HCV viremia decline (P < .01). The estimated reinfection rate was 24.6/100 person-years of observation (95% CI, 11.7-51.6). Among 7 individuals, multiple episodes of HCV reinfection and reclearance were observed. CONCLUSIONS: In this large sample of young IDUs, females show demonstrative differences in their rates of viral clearance and kinetics of early viral decline. Recurring reinfection and reclearance suggest possible protection against persistent infection. These results should inform HCV clinical care and vaccine development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A., & Margolis, H. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410802 · Cited by 2,992
Perz, J. F., Armstrong, G. L., Farrington, L. A., Hutin, Y. J. F., & Bell, B. P. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.013 · Cited by 2,572
Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection
Thimme, R., Oldach, D., Chang, K.-M., Steiger, C., Ray, S. C., & Chisari, F. V. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.10.1395 · Cited by 1,189
HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
Khakoo, S. I., Thio, C. L., Martin, M. P., Brooks, C. R., Gao, X., Astemborski, J., Cheng, J., Goedert, J. J., Vlahov, D., Hilgartner, M., et al. (2004) · Science · doi:10.1126/science.1097670 · Cited by 1,179
[Gastric adenocarcinoma and kidney transplantation].
Barrio, J., García-Bengoechea, M., Emparanza, J. I., & Arenas, J. I. (1998) · PubMed · Cited by 1,132
The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors
Thomas, D. L., Astemborski, J., Rai, R. M., Anania, F. A., Schaeffer, M., Galai, N., Nolt, K., Nelson, K. E., Strathdee, S. A., Johnson, L., et al. (2000) · JAMA · doi:10.1001/jama.284.4.450 · Cited by 1,073
Clinical Outcomes after Hepatitis C Infection from Contaminated Anti-D Immune Globulin
Kenny-Walsh, E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904223401602 · Cited by 910
Micallef, J. M., Kaldor, J. M., & Dore, G. J. (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00651.x · Cited by 871
Gerlach, J. T., Diepolder, H. M., Zachoval, R., Gruener, N. H., Jung, M.-C., Ulsenheimer, A., Schraut, W. W., Schirren, C. A., Waechtler, M., Backmund, M., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00668-1 · Cited by 524
Persistence of Viremia and the Importance of Long–Term Follow–Up After Acute Hepatitis C Infection
Villano, S. A., Vlahov, D., Nelson, K. E., Cohn, S., & Thomas, D. L. (1999) · Hepatology · doi:10.1002/hep.510290311 · Cited by 475
Protection against persistence of hepatitis C
Mehta, S. H., Cox, A., Hoover, D. R., Wang, X.-H., Mao, Q., Ray, S., Strathdee, S. A., Vlahov, D., & Thomas, D. L. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08435-0 · Cited by 440
Wiese, M., Berr, F., Lafrenz, M., Porst, H., & Oesen, U. (2000) · Hepatology · doi:10.1053/jhep.2000.8169 · Cited by 349
Hepatitis C Virus Seroconversion among Young Injection Drug Users: Relationships and Risks
Hahn, J. A., Page‐Shafer, K., Lum, P. J., Bourgois, P., Stein, E., Evans, J. L., Busch, M. P., Tobler, L. H., Phelps, B., & Moss, A. R. (2002) · The Journal of Infectious Diseases · doi:10.1086/345554 · Cited by 326
Self-citationFolgori, A., Capone, S., Ruggeri, L., Meola, A., Sporeno, E., Ercole, B. B., Pezzanera, M., Tafi, R., Arcuri, M., Fattori, E., et al. (2006) · Nature Medicine · doi:10.1038/nm1353 · Cited by 322
Prospects for a vaccine against the hepatitis C virus
Houghton, M., & Abrignani, S. (2005) · Nature · doi:10.1038/nature04081 · Cited by 312
Prospective Evaluation of Community‐Acquired Acute‐Phase Hepatitis C Virus Infection
Cox, A. L., Netski, D. M., Mosbruger, T., Sherman, S. G., Strathdee, S., Ompad, D., Vlahov, D., Chien, D., Shyamala, V., Ray, S. C., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/428578 · Cited by 231
Dynamics of viremia in early hepatitis C virus infection
Glynn, S. A., Wright, D. J., Kleinman, S. H., Hirschkorn, D., Tu, Y., Heldebrant, C., Smith, R., Giachetti, C., Gallarda, J., & Busch, M. P. (2005) · Transfusion · doi:10.1111/j.1537-2995.2005.04390.x · Cited by 217
Self-citationHofer, H., Watkins-Riedel, T., Janata, O., Penner, E., Holzmann, H., Steindl-Munda, P., Gangl, A., & Ferenci, P. (2003) · Hepatology · doi:10.1053/jhep.2003.50019 · Cited by 203
Orland, J. R., Wright, T. L., & Cooper, S. (2001) · Hepatology · doi:10.1053/jhep.2001.22112 · Cited by 196
Self-citationWang, C. C., Krantz, E., Klarquist, J., Krows, M., McBride, L., Scott, E. P., Shaw‐Stiffel, T., Weston, S. J., Thiede, H., Wald, A., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/522608 · Cited by 186
Joly, P., Commenges, D., & Letenneur, L. (1998) · Biometrics · doi:10.2307/2534006 · Cited by 158
Higher clearance of hepatitis C virus infection in females compared with males
Bakr, I., Rekacewicz, C., El Hosseiny, M., Ismail, S., El Daly, M., El-Kafrawy, S., Esmat, G., Hamid, M. A., Mohamed, M. K., & Fontanet, A. (2006) · Gut · doi:10.1136/gut.2005.078147 · Cited by 158
High incidence of hepatitis C virus reinfection in a cohort of injecting drug users
Aitken, C. K., Lewis, J., Tracy, S. L., Spelman, T., Bowden, D. S., Bharadwaj, M., Drummer, H. E., & Hellard, M. E. (2008) · Hepatology · doi:10.1002/hep.22534 · Cited by 129
Santantonio, T., Medda, E., Ferrari, C. I., Fabris, P., Cariti, G., Massari, M., Babudieri, S., Toti, M., Francavilla, R., Ancarani, F., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/507640 · Cited by 115
High incidence of hepatitis C virus reinfection within a cohort of injecting drug users
Micallef, J., Macdonald, V., JAUNCEY, M. E., Amin, J., Rawlinson, W. D., van Beek, I., Kaldor, J. M., White, P. A., & Dore, G. J. (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2006.00812.x · Cited by 110
Hepatocellular Carcinoma and Sex
Wands, J. R. (2007) · New England Journal of Medicine · doi:10.1056/nejmcibr075652 · Cited by 109
Natural course of acute hepatitis C: a long-term prospective study
Santantonio, T. A., Sinisi, E., Guastadisegni, A., Casalino, C., Mazzola, M., Gentile, A., Leandro, G., & Pastore, G. (2003) · Digestive and Liver Disease · doi:10.1016/s1590-8658(03)00007-0 · Cited by 104
Page, K. A., Pappalardo, B. L., Tobler, L. H., Phelps, B. H., Edlin, B. R., Moss, A. R., Wright, T. L., Wright, D. J., OʼBrien, T. R., Caglioti, S., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01229-07 · Cited by 104
Self-citationSpada, E., Mele, A., Berton, A., Ruggeri, L., Ferrigno, L., Garbuglia, A. R., Perrone, M. P., Girelli, G., Porto, P. D., Piccolella, E., et al. (2004) · Gut · doi:10.1136/gut.2003.037788 · Cited by 91
Dixit, V., Quan, S., Martin, P. B., Larson, D., Brezina, M., DiNello, R. K., Sra, K., Lau, J. Y. N., Chien, D. C., & Kolberg, J. A. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.11.2978-2983.1995 · Cited by 87
Larghi, A., Zuin, M. G., Crosignani, A. L., Ribero, M. L., Pipia, C., Battezzati, P. M., Binelli, G., Donato, F., Zanetti, A. R., Podda, M., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.36129 · Cited by 86
Study of host‐ and virus‐related factors associated with spontaneous hepatitis C virus clearance
Alric, L., Fort, M., Izopet, J., Vinel, J. P., Bureau, C., Sandre, K., Charlet, J.-P., Beraud, M., Abbal, M., & Duffaut, M. (2000) · Tissue Antigens · doi:10.1034/j.1399-0039.2000.560207.x · Cited by 74
The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors
Thomas, D. L., Astemborski, J., Rai, R. M., Anania, F. A., Schaeffer, M., Galai, N., Nolt, K. R., Nelson, K. E., Strathdee, S. A., Johnson, L., et al. (2000) · Maryland Shared Open Access Repository (USMAI Consortium) · doi:10.13016/m2ffsj-m7j8 · Cited by 70
Acute Hepatitis C Among Japanese Hemodialysis Patients: A Prospective 9-Year Study
Furusyo, N., Hayashi, J., Kakuda, K., Ariyama, I., Kanamoto-Tanaka, Y., Shimizu, C., Etoh, Y., Shigematsu, M., & Kashiwagi, S. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03701.x · Cited by 69
Potential impact of vaccination on the hepatitis C virus epidemic in injection drug users
Hahn, J. A., Wylie, D., Dill, J. W., Sanchez, M. S., Lloyd‐Smith, J. O., Page, K. A., & Getz, W. M. (2008) · Epidemics · doi:10.1016/j.epidem.2008.10.002 · Cited by 55
Self-citationLefrère, J., Girot, R., Lefrère, F., Guillaume, N., Lerable, J., Marrec, N. L., Bouchardeau, F., & Laperche, S. (2004) · Transfusion · doi:10.1111/j.1537-2995.2004.00656.x · Cited by 48
Beld, M., Penning, M. T., McMorrow, M., Gorgels, J. P. M. C., van den Hoek, A., & Goudsmit, J. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.4.872-877.1998 · Cited by 46
Preventing hepatitis C virus infection in injection drug users: risk reduction is not enough
Page, K. A., Hahn, J. A., & Lum, P. J. (2007) · AIDS · doi:10.1097/qad.0b013e3282ef7701 · Cited by 28
Self-citationAmin, J., Law, M. G., Micallef, J., JAUNCEY, M. E., van Beek, I., Kaldor, J. M., & Dore, G. J. (2006) · Epidemiology and Infection · doi:10.1017/s0950268806006388 · Cited by 28
Cited by
Epidemiology and natural history of HCV infection
Hajarizadeh, B., Grebely, J., & Dore, G. J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.107 · Cited by 994
Ghany, M. G., Morgan, T. R., & Panel, A. H. C. G. (2020) · Hepatology · doi:10.1002/hep.31060 · Cited by 955
Initiation into prescription opioid misuse amongst young injection drug users
Lankenau, S. E., Teti, M., Silva, K., Bloom, J. J., Harocopos, A., & Treese, M. (2012) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2011.05.014 · Cited by 440
“Young injection drugs users (IDUs) – persons aged 30 and younger who currently inject drugs (e.g., Fuller et al., 2001; Roy et al., 2007; Page et al., 2009; Hagan et al., 2010) - are a particularly high-risk subgroup of adolescents and young adults (Thorpe et al., 2002; Davidson et al., 2002;…”
Grebely, J., Page, K., Sacks-Davis, R., van der Loeff, M. S., Rice, T. M., Bruneau, J., Morris, M. D., Hajarizadeh, B., Amin, J., Cox, A. L., et al. (2014) · Hepatology · doi:10.1002/hep.26639 · Cited by 388
Self-citationPlatt, L., Minozzi, S., Reed, J., Vickerman, P., Hagan, H., French, C., Jordan, A., Degenhardt, L., Hope, V., Hutchinson, S., et al. (2018) · Addiction · doi:10.1111/add.14012 · Cited by 362
Metadata
- Authors
- Page, K., Hahn, J. A., Evans, J., Shiboski, S., Lum, P., Delwart, E., Tobler, L., Andrews, W., Avanesyan, L., Cooper, S., & Busch, M. P.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-10-15
- Volume
- 200
- Issue
- 8
- Pages
- 1216-1226
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2101285175
- Cited by
- 285
- References
- 39
- FWCI
- 12.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.